Intra-arterial hepatic chemotherapy for colorectal cancer metastases;Metastases hepatiques des cancers colorectaux: Chimiotherapies intra-arterielles. Interet et indications

Presse Medicale

Volumn 25, Issue 35, 1996, Pages 1683-1688

  Rougier, Ph ^a   Ducreux, M ^a   Elias, D ^a   Lasser, Ph ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT;

CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; DRUG COST; DRUG EFFICACY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; REVIEW; COLORECTAL TUMOR; ECONOMICS; LIVER TUMOR; METASTASIS; PATHOLOGY;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS;

EID: 0029843865     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Rougier P, Milan C, Lazorthes F et al. Unresected hepatic metastases from colorectal cancer: prognostic factor analysis from a prospective study on 544 cases from the Fondation Francaise de Cancérologie Digestive (FFCD). Br J Surg 1995 ; 82:1397-400.
2. Kemeny MM, Goldberg D, Beatty JD et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal cancer. Cancer 1986 ; 57:492-8.
3. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987 ; 206:685-93.
4. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 1987 ; 107:459-65.
5. Hohn DC, Stagg RJ, Friedman MA et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989 ; 7:1646-54.
6. Martin JK, O'Connell MJ, Wieand HS et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 1990 ; 125:1022-7.
7. Rougier P, Laplanche A, Huguier M et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomised trial. J Clin Oncol 1992 ; 10:1112-18.
8. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continous hepatic-artery floxiuridine infusion for colorectal liver metastases. Lancet 1994 ; 344:1255-60.
9. Kemeny N. Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes. In: Important advances in oncology, DeVita VT, Hellman S, Rosenberg SA eds. J.B. Lippincott Company, Philadelphia 1992 :207-28.
10. O'Connell MJ. Is hepatic infusion of chemotherapy effective treatment for liver metastases? No. In: Important advances in oncology, DeVita VT, Hellman S, Rosenberg SA eds. J.B. Lippincott Company, Philadelphia 1992 :229-34.
11. Patt Y. Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues. J Clin Oncol 1993 ; 11:815-19.
12. Patt Y. Hepatic artery chemotherapy for colorectal liver metastases: yet more controversy. J Clin Oncol 1993 ; 11:2053-4.
13. Breedis C, Young C. The blood supply of neoplasm in the liver. Am J Pathol 1954 ; 30:969-74.
14. Chen GHG, Gross JF. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 1980 ; 64:31-40.
15. Ensminger WD, Gyves JW. Regional chemotherapy of neoplastic diseases. Pharmacol Ther 1983 ; 21:277-93.
16. Meta-analysis group in cancer. Reappraisal of hepatic arterial infusion in the treatment of non resectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996 ; 88:252-8.
17. Kemeny N, Conti JA, Cohen A et al. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994 ; 12:2288-95.
18. Rougier P, Ducreux M, Pignon JP et al. Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinous intra-arterial hepatic chemotherapy. Eur J Cancer 1991 ; 10:1226-30.
19. Munck JN, Riggi M, Rougier P et al. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model. Cancer Res 1993 ; 53:1550-4.
20. Munck JN, Rougier Ph, Chabot GG et al. Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastases. Eur J Cancer 1994 ; 30A:289-94.
21. Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 1986 ; 57:465-70.
22. Rougier Ph, Ducreux M, Ychou M et al. Intra-arterial hepatic chemotherapy using mitomycin C combined to intra-veinous chemotherapy using 5FU + folinic acid for hepatic metastases from colorectal cancer. Proc Am Soc Clin Oncol 1996 ; 15:206.
23. Villanova G, Ducreux M, Samelis G et al. Chimiotht́rapie intraartérielle hépatique par 5-fluorouracile en perfusion continue associé à un traitement intraveineux par 5FU et acide folinique. Bull Cancer 1996 ; 83:439.
24. Safi F, Hepp G, Link KH, Beger HG. Simultaneous adjuvant regional and systemic chemotherapy after resection of liver metastases of colorectal cancer. Proc Am Soc Clin Oncol 1995 ; 14:217.
25. Elias D, Lasser P, Rougier P. A simplified surgical technical procedure for intra-arterial chemotherapy in secondary liver cancer. Experience in 50 patients. Eur J Surg Oncol 1987 ; 13:441-8.
26. Mahjoubi R, Ychou M, Ducreux M et al. Multicentric phase II trial of intrahepatic arterial (HAI) pirarubicin (P) and systemic 5 fluorouracil (5FU) + leucovorin (LV) for liver metastases (LM) from colorectal cancer (CRC). Proc Am Soc Clin Oncol 1994 ; 13:223.
27. Kemeny N, Cohen A, Seiter K et al. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 1993 ; 11:330-5.
28. Kemeny N, Conti JA, Sigurdson E et al. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. Cancer 1993 ; 71:1964-71.
29. Elias D, Ducreux M, Rougier Ph et al. Chimiothérapie intra-artérielle hépatique. Expérience de 200 cas. Gastroenterol Clin Biol 1994 ; 18:975-82.
30. Peters GJ, Van der Wilt CL, Van Groeningen CJ, Smid K, Meijer S, Pinedo HM. Thymidilate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J Clin Oncol 1994 ; 12:2035-42.
31. Link KH, Kornmann M, Lenz HJ et al. Response prediction in hepatic artery infusion with fluoropyrimidines using cell culture and thymidilate synthase quantitation. Reg Cancer Treat 1995 ; 8:115-21.
32. Elias D, Lasser P, Rougier P, Ducreux M, Bognel C, Roche A. Frequency, technical aspects, results and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995 ; 180:213-21.